310 related articles for article (PubMed ID: 28810291)
1. [Correlation between extranodal invasion in axillary lymph node metastasis and prognosis of breast cancer patients].
Zhang LL; Ma L; Geng CZ; Jia Y; Wang XL; Liu YP
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):525-529. PubMed ID: 28810291
[No Abstract] [Full Text] [Related]
2. Prognostic value of extranodal extension in axillary lymph node-positive breast cancer.
Ma X; Yang X; Yang W; Shui R
Sci Rep; 2021 May; 11(1):9534. PubMed ID: 33953240
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for axillary dissection for patients with operable breast cancer in this era of conservatism?
Chua B; Ung O; Taylor R; Boyages J
ANZ J Surg; 2002 Nov; 72(11):786-92. PubMed ID: 12437688
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic role of axillary lymph node dissection in patients with stage IV breast cancer: a population-based analysis.
Wu SG; Li FY; Chen Y; Sun JY; Lin HX; Lin Q; He ZY
J Cancer Res Clin Oncol; 2017 Mar; 143(3):467-474. PubMed ID: 27812853
[TBL] [Abstract][Full Text] [Related]
6. Size of Extranodal Extension on Sentinel Lymph Node Dissection in the American College of Surgeons Oncology Group Z0011 Trial Era.
Choi AH; Blount S; Perez MN; Chavez de Paz CE; Rodriguez SA; Surrusco M; Garberoglio CA; Lum SS; Senthil M
JAMA Surg; 2015 Dec; 150(12):1141-8. PubMed ID: 26331347
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of extranodal extension in sentinel lymph node positive breast cancer.
Yang X; Ma X; Yang W; Shui R
Sci Rep; 2020 Sep; 10(1):14684. PubMed ID: 32895434
[TBL] [Abstract][Full Text] [Related]
8. Anatomical site and size of sentinel lymph node metastasis predicted additional axillary tumour burden and breast cancer survival.
Lai BS; Tsang JY; Li JJ; Poon IK; Tse GM
Histopathology; 2023 May; 82(6):899-911. PubMed ID: 36723261
[TBL] [Abstract][Full Text] [Related]
9. Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis.
Nottegar A; Veronese N; Senthil M; Roumen RM; Stubbs B; Choi AH; Verheuvel NC; Solmi M; Pea A; Capelli P; Fassan M; Sergi G; Manzato E; Maruzzo M; Bagante F; Koç M; Eryilmaz MA; Bria E; Carbognin L; Bonetti F; Barbareschi M; Luchini C
Eur J Surg Oncol; 2016 Jul; 42(7):919-25. PubMed ID: 27005805
[TBL] [Abstract][Full Text] [Related]
10. The characteristics of the sentinel lymph node metastasis in predicting the axillary lymph node status in patients with breast carcinoma.
Olszewski WP; Szumera-Ciećkiewicz A; Piechocki J; Towpik E; Olszewski WT
Pol J Pathol; 2009; 60(3):138-43. PubMed ID: 20069508
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration.
Yu Y; Cui N; Li HY; Wu YM; Xu L; Fang M; Sheng Y
BMC Cancer; 2016 Oct; 16(1):808. PubMed ID: 27756234
[TBL] [Abstract][Full Text] [Related]
12. A prediction model for the presence of axillary lymph node involvement in women with invasive breast cancer: a focus on older women.
Greer LT; Rosman M; Charles Mylander W; Liang W; Buras RR; Chagpar AB; Edwards MJ; Tafra L
Breast J; 2014; 20(2):147-53. PubMed ID: 24475876
[TBL] [Abstract][Full Text] [Related]
13. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of primary tumor parameters using
Yoo J; Kim BS; Yoon HJ
Ann Nucl Med; 2018 Nov; 32(9):642-648. PubMed ID: 30094546
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study.
Gillanders WE; Mikhitarian K; Hebert R; Mauldin PD; Palesch Y; Walters C; Urist MM; Mann GB; Doherty G; Herrmann VM; Hill AD; Eremin O; El-Sheemy M; Orr RK; Valle AA; Henderson MA; Dewitty RL; Sugg SL; Frykberg E; Yeh K; Bell RM; Metcalf JS; Elliott BM; Brothers T; Robison J; Mitas M; Cole DJ
Ann Surg; 2004 Jun; 239(6):828-37; discussion 837-40. PubMed ID: 15166962
[TBL] [Abstract][Full Text] [Related]
16. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
[No Abstract] [Full Text] [Related]
17. False negative results in axillary lymph nodes by ultrasonography and ultrasonography-guided fine-needle aspiration in patients with invasive ductal carcinoma.
Park SH; Kim EK; Park BW; Kim SI; Moon HJ; Kim MJ
Ultraschall Med; 2013 Dec; 34(6):559-67. PubMed ID: 23258771
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer.
Park S; Lee JE; Paik HJ; Ryu JM; Bae SY; Lee SK; Kim SW; Nam SJ
Clin Breast Cancer; 2017 Feb; 17(1):e19-e29. PubMed ID: 27495997
[TBL] [Abstract][Full Text] [Related]
19. The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
Madekivi V; Boström P; Aaltonen R; Vahlberg T; Salminen E
Anticancer Res; 2017 Jul; 37(7):3757-3762. PubMed ID: 28668871
[TBL] [Abstract][Full Text] [Related]
20. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma.
Shen J; Hunt KK; Mirza NQ; Krishnamurthy S; Singletary SE; Kuerer HM; Meric-Bernstam F; Feig B; Ross MI; Ames FC; Babiera GV
Cancer; 2004 Sep; 101(6):1330-7. PubMed ID: 15316905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
